Skip to main content
Equibles

Ikarian Capital, LLC

Position in JSPR — Jasper Therapeutics, Inc.

CIK 1778253 DALLAS, TX
Back to JSPR Full portfolio

Position in JSPR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$10,143
-$10,962 QoQ
Shares Held
24,093
0.0% QoQ
Ownership
0.072%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 44 holders
Holding Since
Mar 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in JSPR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names. JSPR ranks #103 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 328,635 $43,793,900
2 KOD
Kodiak Sciences Inc.
 1,059,730 $41,287,080
3 ALMS
Alumis Inc.
 870,548 $24,497,220
4 PRAX
Praxis Precision Medicines, Inc.
 72,842 $24,386,773
5 PCVX
Vaxcyte, Inc.
 388,682 $22,594,084
6 CLDX
Celldex Therapeutics, Inc.
 478,500 $17,804,985
7 RCUS
Arcus Biosciences, Inc.
 504,559 $15,555,553
8 RLMD
Relmada Therapeutics, Inc.
 2,148,359 $14,866,644

All Filings in JSPR

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,143 24,093
2026-03-31 $21,105 24,093
2025-12-31 $44,090 24,093
2025-09-30 $59,754 25,107
2025-06-30 $139,343 25,107
2025-03-31 $107,960 25,107
2024-12-31 $1,178,187 55,107
2024-09-30 $1,037,841 55,175
2024-06-30 $2,387,472 105,175
2024-03-31 $3,087,938 105,175
2023-09-30 $787,560 1,125,087
2023-06-30 $1,541,369 1,125,087
2023-03-31 $2,038,579 1,126,287